Zepbound 2.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FM9F2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $79,298
Award facts
- Contract value 100% obligated
- $79,297.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $79,298 delivery order to AmerisourceBergen Drug Corp on January 8, 2026, for the supply of Zepbound 2.5 mg/0.5 mL pen injections (0.5 mL units). This is a firm fixed-price contract with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The work will be performed at the contractor's headquarters in Conshohocken, Pennsylvania, with a completion date of January 9, 2026. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal healthcare systems including the Department of Defense and Veterans Affairs.
This delivery order represents a single task order under AmerisourceBergen's comprehensive $1 billion IDC with DLA Troop Support Medical, which extends through December 2026 and serves as a global pharmaceutical support vehicle for military healthcare programs. The IDC encompasses a broad range of pharmaceutical products, vaccines, and medical supplies across multiple therapeutic domains. Zepbound, a GLP-1 receptor agonist used in diabetes and obesity treatment, aligns with the company's extensive portfolio of specialty medications supplied to federal military treatment facilities and veteran healthcare programs. The competitively awarded nature of this contract reflects AmerisourceBergen's established capability to meet federal procurement requirements in the pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DR26FM9F2?
SPE2DR26FM9F2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26FM9F2 worth?
The government has obligated $79,298 on SPE2DR26FM9F2.
Is contract SPE2DR26FM9F2 an order under another contract?
Yes. SPE2DR26FM9F2 is a delivery order under SPE2DR25D2211, an indefinite delivery contract.
Was contract SPE2DR26FM9F2 competed?
The extent of competition for SPE2DR26FM9F2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award